AstraZeneca Aktie
139,85 EUR -2,45 EUR -1,72 %
STU
1.525,00 SEK -30,00 SEK -1,93 %
STO
Werbung
AstraZeneca Rating
AstraZeneca PLC Aktie Moody's Rating
A1
C
A3
Aaa
Investmentwürdig - Hohe Sicherheit
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
| Rating | A1 | Rating Typ Bank Financial Strength Rating Insurance Financial Strength Rating Enhanced Rating Insured Rating Long-Term Bank Deposit Rating Long-Term OSO Rating Long-Term Debt Rating Money Market Fund Rating Modeled Shadow Rating Management Quality Rating Probability of Default Rating Pfd/Pref Stock Rating Prospective Pfd/Pref Rating Short-Term Bank Deposit Rating Speculative Grade Liquidity Rating Prospective LT Debt Rating Short-Term Insurance Financial Strength Rating Short-Term OSO Rating Servicer Quality Short-Term Debt Rating Lloyd´s Syndicate Performance Rating Underlying Rating Unknown - for conversion use only | Long-Term Debt Rating |
| Letzte Aktion | Upgrade | Moody's Büro in | - |
Anleihen von AstraZeneca PLC mit Moody's Ratings
| Emittent | Anzahl Anleihen | Ratings |
|---|---|---|
| AstraZeneca PLC | 16 | A1 |
Werbung
Werbung